← Leaderboards
Douglas A Lappi
Advanced Targeting Systems, Inc.
$8,474,117
Attributed
$8,474,117
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$8,474,117 · 11
By mechanism
R44$4,626,579 · 3
RC3$3,000,000 · 1
R43$847,538 · 7
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsChemical ConjugateLaboratory MouseSubstance PSpinal CordCell TypeChronic PainEndodeoxyribonucleaseLaboratory RatDrug DevelopmentCellsAnalgesicsPainTechnologyNeurobiologyOpioid ReceptorDrug Adverse EffectCell SurfaceDorsal HornDrug Screening /EvaluationBaseAutoradiographyBiotechnologyBrain Disorder Diagnosis
Grant awards (19)
Enhancing CRISPR-based Therapeutic Interventions Via a Targeted Platform Tool$150,000
R43 · FY2017 · TR · contact PI
Development of a Novel Cancer Pain Therapeutic$3,000,000
RC3 · FY2010 · CA · contact PI
Targeting a Poor Prognosis Marker for Tumor Therapy$150,480
R43 · FY2010 · CA · contact PI
Selective Activation in Specific Neuronal Populations$99,175
R43 · FY2009 · AG · contact PI
Inhibition of Neurotransmission in Specific Neuronal Populations$114,336
R43 · FY2008 · MH · contact PI
Drug Development of a Chronic Pain Therapeutic$789,215
R44 · FY2005 · MH
Monoclonal Antibodies to Target Neuronal Populations$174,879
R44 · FY2005 · MH
Drug Development of a Chronic Pain Therapeutic$799,999
R44 · FY2004 · MH
Monoclonal Antibodies to Target Neuronal Populations$282,193
R44 · FY2004 · MH
Drug Development of a Chronic Pain Therapeutic$799,709
R44 · FY2003 · MH
Monoclonal Antibodies to Target Neuronal Populations$341,281
R44 · FY2003 · MH
A Specific Tool for Targeting Neurodegeneration$245,067
R44 · FY2003 · NS
NEW TOOLS FOR BASIC NEUROBIOLOGICAL RESEARCH$276,089
R44 · FY2002 · MH
A Specific Tool for Targeting Neurodegeneration$237,928
R44 · FY2002 · NS
Isolation of Pancreatic Islets by FACS$100,000
R43 · FY2002 · DK
TOXICOLOGY/SAFETY STUDIES OF A CHRONIC PAIN THERAPEUTIC$397,984
R44 · FY2001 · MH
A Specific Tool for Targeting Neurodegeneration$282,235
R44 · FY2001 · NS
Targeting Neurons Involved in Chronic Pain Transmission$133,547
R43 · FY2001 · DE
A TOOL TO STUDY THE DIVERSE BEHAVIOR EFFECTS OF GALANIN$100,000
R43 · FY2000 · DA